Dosimetric analysis of the patterns of local failure observed in patients with locally advanced non-small cell lung cancer treated with neoadjuvant chemotherapy and concurrent conformal (3D-CRT) chemoradiation

Radiotherapy and Oncology

Volumn 88, Issue 3, 2008, Pages 342-350

  Moreno Jiménez, Marta ^a   Aristu, Javier ^a   López Picazo, José María ^a   Ramos, Luis Isaac ^a   Gúrpide, Alfonso ^a   Gómez Iturriaga, Alfonso ^a   Valero, Jeannete ^a   Martínez Monge, Rafael ^a  

^a UNIVERSITY CLINIC OF NAVARRA   (Spain)

Author keywords

3D conformal radiotherapy; Combined modality; Failure patterns; Hyperfractionation; Local failure; Unresectable non small cell lung cancer

Indexed keywords

CISPLATIN; GEMCITABINE; NAVELBINE; PACLITAXEL;

ADJUVANT THERAPY; ADVANCED CANCER; ARTICLE; CANCER CHEMOTHERAPY; CANCER LOCALIZATION; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CLINICAL EVALUATION; COMBINATION CHEMOTHERAPY; COMPUTER ASSISTED RADIOTHERAPY; CONTROLLED STUDY; FEMALE; HUMAN; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; RADIATION DOSE FRACTIONATION; TREATMENT FAILURE;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, NON-SMALL-CELL LUNG; CHEMOTHERAPY, ADJUVANT; CISPLATIN; COMBINED MODALITY THERAPY; DOSE-RESPONSE RELATIONSHIP, RADIATION; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOADJUVANT THERAPY; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROGNOSIS; RADIOMETRY; RADIOTHERAPY DOSAGE; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RADIOTHERAPY, CONFORMAL; TREATMENT FAILURE;

EID: 52049113897     PISSN: 01678140     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.radonc.2008.05.019     Document Type: Article

References (69)

1. Schrump D.S., Altorki N.K., Henschke C.L., Carter D., Turrisi A., and Gutierrez M.E. Non-small cell lung cancer. In: De Vita V.T., Hellman S., and Rosenberg S.A. (Eds). Principles and practice of oncology (2005), Lippincott, Philadelphia, PA 753-810
2. Blanke C., Ansari R., Mantravadi R., Gonin R., Tokars R., Fisher W., et al. Phase III trial of thoracic irradiation with or without cisplatin for locally advanced unresectable non-small-cell lung cancer: a Hoosier Oncology Group protocol. J Clin Oncol 13 (1995) 1425-1429
3. Choy H., Akerley W., Safran H., Graziano S., Chung C., Williams T., et al. Multiinstitutional phase II trial of paclitaxel, carboplatin, and concurrent radiation therapy for locally advanced non-small-cell lung cancer. J Clin Oncol 16 (1998) 3316-3322
4. Furuse K., Fukuoka M., Kawahara M., Nishikawa H., Takada Y., Kudoh S., et al. Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non-small-cell lung cancer. J Clin Oncol 17 (1999) 2692-2699
5. Schaake-Koning C., van den Bogaert W., Dalesio O., Festen J., Hoogenhout J., van Houtte P., et al. Effects of concomitant cisplatin and radiotherapy on inoperable non-small-cell lung cancer. N Engl J Med 326 (1992) 524-530
6. Vokes E.E., Herndon J.E., Crawford J., Leopold K.A., Perry M.C., Miller A.A., et al. Randomized phase II study of cisplatin with gemcitabine or paclitaxel or vinorelbine as induction chemotherapy followed by concomitant chemoradiotherapy for stage IIIB non-small-cell lung cancer: cancer and leukemia group B study 9431. J Clin Oncol 20 (2002) 4191-4198
7. Leibel S.A., Ling C.C., Kutcher G.J., Mohan R., Cordon-Cordo C., and Fuks Z. The biological basis for conformal three-dimensional radiation therapy. Int J Radiat Oncol Biol Phys 21 (1991) 805-811
8. Byhardt R.W., Scott C., Sause W.T., Emami B., Komaki R., Fisher B., et al. Response, toxicity, failure patterns, and survival in five Radiation Therapy Oncology Group (RTOG) trials of sequential and/or concurrent chemotherapy and radiotherapy for locally advanced non-small-cell carcinoma of the lung. Int J Radiat Oncol Biol Phys 42 (1998) 469-478
9. Gould P.M., Bonner J.A., Sawyer T.E., Deschamps C., Lange C.M., and Li H. Patterns of failure and overall survival in patients with completely resected T3 N0 M0 non-small cell lung cancer. Int J Radiat Oncol Biol Phys 45 (1999) 91-95
10. Perez C.A., Pajak T.F., Rubin P., Simpson J.R., Mohiuddin M., Brady L.W., et al. Long-term observations of the patterns of failure in patients with unresectable non-oat cell carcinoma of the lung treated with definitive radiotherapy. Report by the Radiation Therapy Oncology Group. Cancer 59 (1987) 1874-1881
11. Moreno Jimenez M., Aristu J., Arbea L., Garrán C., Cambeiro M., López-Picazo J.M., et al. Radiation pneumonitis following combined modality therapy in the treatment of locally advanced non-small cell lung cancer (LAD-NSCLC) including three-dimensional conformal radiation therapy (3D-CRT): analysis of clinical and dosimetric prognostic factors. Eur J Cancer Suppl 3 (2005) 330 [abstr. 1142]
12. Moreno Jimenez M., Aristu J., Ramos L.I., Arbea L., López-Picazo J.M., Cambeiro M., et al. Predictive factors for radiation-induced pulmonary toxicity after three-dimensional conformal chemoradiation in locally advanced non-small-cell lung cancer. Clin Transl Oncol 9 (2007) 596-602
13. Mountain C.F. Revisions in the international system for staging lung cancer. Chest 111 (1997) 1710-1717
14. International commission on radiation and measurements. Prescribing, recording, and reporting photon beam therapy, ICRU 50. Bethesda, USA; 1993.
15. International commission on radiation and measurements. Prescribing, recording, and reporting photon beam therapy, ICRU 62. Bethesda, USA; 1999.
16. Kaplan E.L., and Meier P. Non parametric estimation from incomplete observations. J Am Stat Assoc 53 (1958) 457-481
17. Cox DR Oakes D. Analysis of survival data (1984), Chapman and Hall, London
18. Byhardt R., Scott C., Sause W., Emami B., Komaki R., Fisher B., et al. Response, toxicity, failure patterns and survival in five radiation therapy oncology group (RTOG) trials of sequential and/or concurrent chemotherapy (CT) and radiation therapy (RT) for locally advanced non-small cell carcinoma of the lung (NSCLC). Int J Radiat Oncol Biol Phys 39 (1997) 195
19. Choy H., DeVore III R.F., Hande K.R., Porter L.L., Rosenblatt P., Yunus F., et al. A phase II study of paclitaxel, carboplatin, and hyperfractionated radiation therapy for locally advanced inoperable non-small-cell lung cancer (a Vanderbilt Cancer Center Affiliate Network Study). Int J Radiat Oncol Biol Phys 47 (2000) 931-937
20. Jeremic B., Shibamoto Y., Acimovic L., and Milisavljevic S. Hyperfractionated radiation therapy with or without concurrent low-dose daily carboplatin/etoposide for stage III non-small-cell lung cancer: a randomized study. J Clin Oncol 14 (1996) 1065-1070
21. Jeremic B., Shibamoto Y., Acimovic L., Milicic B., Milisavljevic S., Nikolic N., et al. Hyperfractionated radiation therapy and concurrent low-dose, daily carboplatin/etoposide with or without weekend carboplatin/etoposide chemotherapy in stage III non-small-cell lung cancer: a randomized trial. Int J Radiat Oncol Biol Phys 50 (2001) 19-25
22. Komaki R., Scott C., Ettinger D., Lee J.S., Fossella F.V., Curran W., et al. Randomized study of chemotherapy/radiation therapy combinations for favorable patients with locally advanced inoperable nonsmall cell lung cancer: Radiation Therapy Oncology Group (RTOG) 92-04. Int J Radiat Oncol Biol Phys 38 (1997) 149-155
23. Lee J.S., Scott C., Komaki R., Fossella F.V., Dundas G.S., McDonald S., et al. Concurrent chemoradiation therapy with oral etoposide and cisplatin for locally advanced inoperable non-small-cell lung cancer: radiation therapy oncology group protocol 91-06. J Clin Oncol 14 (1996) 1055-1064
24. Lee J.S., Komaki R., Fossella F.V., Glisson B.S., Hong W.K., and Cox J.D. A pilot trial of hyperfractionated thoracic radiation therapy with concurrent cisplatin and oral etoposide for locally advanced inoperable non-small-cell lung cancer: a 5-year follow-up report. Int J Radiat Oncol Biol Phys 42 (1998) 479-486
25. Lee S.W., Choi E.K., Lee J.S., Lee S.D., Suh C., Kim S.W., et al. Phase II study of three-dimensional conformal radiotherapy and concurrent mitomycin-C, vinblastine, and cisplatin chemotherapy for Stage III locally advanced, unresectable, non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 56 (2003) 996-1004
26. Dillman R.O., Seagren S.L., Propert K.J., Guerra J., Eaton W.L., Perry M.C., et al. A randomized trial of induction chemotherapy plus high-dose radiation versus radiation alone in stage III non-small-cell lung cancer. N Engl J Med 323 (1990) 940-945
27. Dillman R.O., Herndon J., Seagren S.L., Eaton W.L.J., and Green M.R. Improved survival in stage III non-small-cell lung cancer: seven-year follow-up of cancer and leukemia group B (CALGB) 8433 trial. J Natl Cancer Inst 88 (1996) 1210-1215
28. Le Chevalier T., Arriagada R., Quoix E., Ruffie P., Martin M., Tarayre M., et al. Radiotherapy alone versus combined chemotherapy and radiotherapy in nonresectable non-small-cell lung cancer: first analysis of a randomized trial in 353 patients. J Natl Cancer Inst 83 (1991) 417-423
29. Mattson K., Holsti L.R., Holsti P., Jakobsson M., Kajanti M., Liippo K., et al. Inoperable non-small cell lung cancer: radiation with or without chemotherapy. Eur J Cancer Clin Oncol 24 (1988) 477-482
30. Morton R.F., Jett J.R., McGinnis W.L., Earle J.D., Therneau T.M., Krook J.E., et al. Thoracic radiation therapy alone compared with combined chemoradiotherapy for locally unresectable non-small cell lung cancer. A randomized, phase III trial. Ann Intern Med 115 (1991) 681-686
31. Sause W, Kolesar P, Taylor S, Johnson D, Livingston R, Komaki R, et al. Five-year results; phase III trial of regionally advanced unresectable non-small cell lung cancer, RTOG 8808, ECOG 4588, SWOG 8992. In: Proceedings of American Society of Clinical Oncology (ASCO), Abstract 1743; 1998.
32. Sause W., Kolesar P., Taylor IV S., Johnson D., Livingston R., Komaki R., et al. Final results of phase III trial in regionally advanced unresectable non-small cell lung cancer: Radiation Therapy Oncology Group, Eastern Cooperative Oncology Group, and Southwest Oncology Group. Chest 117 (2000) 358-364
33. Sause W.T., Scott C., Taylor S., Johnson D., Livingston R., Komaki R., et al. Radiation Therapy Oncology Group (RTOG) 88-08 and Eastern Cooperative Oncology Group (ECOG) 4588: preliminary results of a phase III trial in regionally advanced, unresectable non-small-cell lung cancer. J Natl Cancer Inst 87 (1995) 198-205
34. Bahri S., Flickinger J.C., Kalend A.M., Deutsch M., Belani C.P., Sciurba F.C., et al. Results of multifield conformal radiation therapy of nonsmall-cell lung carcinoma using multileaf collimation beams. Radiat Oncol Investig 7 (1999) 297-308
35. Bhatnagar A., Flickinger J.C., Bahri S., Deutsch M., Belani C., Luketich J.D., et al. Update on results of multifield conformal radiation therapy of non-small-cell lung cancer using multileaf collimated beams. Clin Lung Cancer 3 (2002) 259-264
36. Bradley J.D., Ieumwananonthachai N., Purdy J.A., Wasserman T.H., Lockett M.A., Graham M.V., et al. Gross tumor volume, critical prognostic factor in patients treated with three-dimensional conformal radiation therapy for non-small-cell lung carcinoma. Int J Radiat Oncol Biol Phys 52 (2002) 49-57
37. Chen L.M., Ignacio L., Jacobs R., Kozloff M., Telfer M., Elahi R., et al. Results of a phase II concurrent chemoradiotherapy study using three-dimensional conformal radiotherapy with cisplatin and oral etoposide in stage III nonsmall-cell lung cancer. Radiat Oncol Investig 7 (1999) 49-53
38. Hayman J.A., Martel M.K., Ten Haken R.K., Normolle D.P., Todd R.F., Littles J.F., et al. Dose escalation in non-small-cell lung cancer using three-dimensional conformal radiation therapy: update of a phase i trial. J Clin Oncol 19 (2001) 127-136
39. Hernando M.L., Marks L.B., Bentel G.C., Zhou S.M., Hollis D., Das S.K., et al. Radiation-induced pulmonary toxicity: a dose-volume histogram analysis in 201 patients with lung cancer. Int J Radiat Oncol Biol Phys 51 (2001) 650-659
40. Morris D.E., Rosenman J.G., Halle J., Hensing T.A., Limentani S., Fraser R., et al. Induction chemotherapy followed by dose-escalated thoracic 3-dimensional conformal radiation therapy to 90 Gy with concurrent chemotherapy. Int J Radiat Oncol Biol Phys 57 (2003) S138
41. Pottgen C., Eberhardt W., Bildat S., Stuben G., Stamatis G., Hillejan L., et al. Induction chemotherapy followed by concurrent chemotherapy and definitive high-dose radiotherapy for patients with locally advanced non-small-cell lung cancer (stages IIIa/IIIb): a pilot phase I/II trial. Ann Oncol 13 (2002) 403-411
42. Rosenman J.G., Halle J.S., Socinski M.A., Deschesne K., Moore D.T., Johnson H., et al. High-dose conformal radiotherapy for treatment of stage IIIA/IIIB non-small-cell lung cancer: technical issues and results of a phase I/II trial. Int J Radiat Oncol Biol Phys 54 (2002) 348-356
43. Rosenzweig K.E., Sim S.E., Mychalczak B., Schindelheim R., Fuks Z., and Leibel S. Elective nodal irradiaiton in the treatment of non-small cell lung cancer with three-dimensional conformal radiation therapy (3D-CRT). Int J Radiat Oncol Biol Phys 45 (1999) 245
44. Senan S., Burgers S., Samson M.J., van Klaveren R.J., Oei S.S., van Sornsen D.K., et al. Can elective nodal irradiation be omitted in stage III non-small-cell lung cancer? Analysis of recurrences in a phase II study of induction chemotherapy and involved-field radiotherapy. Int J Radiat Oncol Biol Phys 54 (2002) 999-1006
45. Sibley G.S., Mundt A.J., Shapiro C., Jacobs R., Chen G., Weichselbaum R., et al. The treatment of stage III nonsmall cell lung cancer using high dose conformal radiotherapy. Int J Radiat Oncol Biol Phys 33 (1995) 1001-1007
46. Sim S., Rosenzweig K.E., Schindelheim R., Ng K.K., and Leibel S.A. Induction chemotherapy plus three-dimensional conformal radiation therapy in the definitive treatment of locally advanced non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 51 (2001) 660-665
47. Socinski M.A., Clark J.A., Halle J., Steagall A., Kaluzny B., and Rosenman J.G. Induction therapy with carboplatin/paclitaxel followed by concurrent carboplatin/paclitaxel and dose-escalating conformal radiotherapy in the treatment of locally advanced, unresectable non-small cell lung cancer: preliminary report of a phase I trial. Semin Oncol 24 (1997) S12
48. Sunyach M.P., Falchero L., Pommier P., Perol M., Arpin D., Vincent M., et al. Prospective evaluation of early lung toxicity following three-dimensional conformal radiation therapy in non-small-cell lung cancer: preliminary results. Int J Radiat Oncol Biol Phys 48 (2000) 459-463
49. Tsujino K., Hirota S., Endo M., Obayashi K., Kotani Y., Satouchi M., et al. Predictive value of dose-volume histogram parameters for predicting radiation pneumonitis after concurrent chemoradiation for lung cancer. Int J Radiat Oncol Biol Phys 55 (2003) 110-115
50. Willner J., Schmidt M., Kirschner J., Lang S., Borgmeier A., Huber R.M., et al. Sequential chemo- and radiochemotherapy with weekly paclitaxel (Taxol) and 3D-conformal radiotherapy of stage III inoperable non-small cell lung cancer. Results of a dose escalation study. Lung Cancer 32 (2001) 163-171
51. Willner J, Huber MH, Poellinger B, Gosse H, Friedrich A, Mose S, et al., CTRT 99/97 A randomized trial of simultaneous paclitaxel and radiotherapy vs radiotherapy alone following induction chemotherapy in stage III inoperable NSCLC. In: Proceedings of the 45nd annual ASTRO meeting, vol. 57(2); 2003. p. S140.
52. Wu K.L., Jiang G.L., Liao Y., Qian H., Wang L.J., Fu X.L., et al. Three-dimensional conformal radiation therapy for non-small-cell lung cancer: a phase I/II dose escalation clinical trial. Int J Radiat Oncol Biol Phys 57 (2003) 1336-1344
53. Fletcher G.H. Clinical dose response curves of human malignant epithelial tumours. Br J Radiol 46 (1973) 151
54. Bradley J.D., Deasy J.O., Purdy J.A., Wasserman T., Graham M.V., Ieumwananonthachai N., et al. Gross tumor volume is a independent predictor of survival in non-small cell lung carcinoma patients treated with conformal radiotherapy. Int J Radiat Oncol Biol Phys 48 (2003) 129-130
55. Chen M., Jiang G.L., Fu X.L., Wang L.J., Qian H., Zhao S., et al. Prognostic factors for local control in non-small-cell lung cancer treated with definitive radiation therapy. Am J Clin Oncol 25 (2002) 76-80
56. Coy P., and Kennelly G.M. The role of curative radiotherapy in the treatment of lung cancer. Cancer 45 (1980) 698-702
57. Etiz D., Marks L.B., Zhou S.M., Bentel G.C., Clough R., Hernando M.L., et al. Influence of tumor volume on survival in patients irradiated for non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 53 (2002) 835-846
58. Kupelian P.A., Komaki R., and Allen P. Prognostic factors in the treatment of node-negative nonsmall cell lung carcinoma with radiotherapy alone. Int J Radiat Oncol Biol Phys 36 (1996) 607-613
59. Martel M.K., Strawderman M., Hazuka M.B., Turrisi A.T., Fraass B.A., and Lichter A.S. Volume and dose parameters for survival of non-small cell lung cancer patients. Radiother Oncol 44 (1997) 23-29
60. Morita K., Fuwa N., Suzuki Y., Nishio M., Sakai K., Tamaki Y., et al. Radical radiotherapy for medically inoperable non-small cell lung cancer in clinical stage I: a retrospective analysis of 149 patients. Radiother Oncol 42 (1997) 31-36
61. Noordijk E.M., vd Poest C.E., Hermans J., Wever A.M., and Leer J.W. Radiotherapy as an alternative to surgery in elderly patients with resectable lung cancer. Radiother Oncol 13 (1988) 83-89
62. Perez C.A., Stanley K., Grundy G., Hanson W., Rubin P., Kramer S., et al. Impact of irradiation technique and tumor extent in tumor control and survival of patients with unresectable non-oat cell carcinoma of the lung: report by the Radiation Therapy Oncology Group. Cancer 50 (1982) 1091-1099
63. Wigren T., Oksanen H., and Kellokumpu-Lehtinen P. A practical prognostic index for inoperable non-small-cell lung cancer. J Cancer Res Clin Oncol 123 (1997) 259-266
64. van Baardwijk A., Baumert B.G., Bosmans G., van Kroonenburgh M., Stroobants S., Gregoire V., et al. The current status of FDG-PET in tumour volume definition in radiotherapy treatment planning. Cancer Treat Rev 32 (2006) 245-260
65. Lavrenkov K., Partridge M., Cook G., and Brada M. Positron emission tomography for target volume definition in the treatment of non-small cell lung cancer. Radiother Oncol 77 (2005) 1-4
66. George R., Chung T.D., Vedam S.S., Ramakrishnan V., Mohan R., Weiss E., et al. Audio-visual biofeedback for respiratory-gated radiotherapy: impact of audio instruction and audio-visual biofeedback on respiratory-gated radiotherapy. Int J Radiat Oncol Biol Phys 65 (2006) 924-933
67. Keall P., Vedam S., George R., Bartee C., Siebers J., Lerma F., et al. The clinical implementation of respiratory-gated intensity-modulated radiotherapy. Med Dosim 31 (2006) 152-162
68. Willner J., Baier K., Caragiani E., Tschammler A., and Flentje M. Dose, volume, and tumor control prediction in primary radiotherapy of non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 52 (2002) 382-389
69. Chien C.R., Chen S.W., Hsieh C.Y., Liang J.A., Yang S.N., Huang C.Y., et al. Intra-thoracic failure pattern and survival status following 3D conformal radiotherapy for non-small cell lung cancer: a preliminary report. Jpn J Clin Oncol 31 (2001) 55-60